EKSO

#4426
Ekso Bionics Holdings, Inc. Common Stock
11.3700 USD
+1.70%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
11.3700
11.3700
Faixa anual
7.8900
13.5000
Mudança diária
+1.70%
Mudança mensal
+13.59%
Mudança em 6 meses
-9.19%
Mudança anual
-9.19%
Fechamento anterior
11.1800
Abrir
11.3700
Mínimo
11.3700
High
11.3700
Volume
1
Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 40.5156 M
  • Employee 55
  • Founded 2005
  • CEO Scott Davis
  • Website www.eksobionics.com
  • Headquarter Nevada, United States
  • FIGI BBG002Z0NKK4
  • Industry Instrumentos médicos e consumíveis
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-1.76
Índice preço/fluxo de caixa
1.64

Ekso Bionics Holdings Inc

Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk. Ekso Bionics currently focuses in the health and industrial sectors. The company's first commercially available health product was called EksoGT. Ekso Bionics is the original developer of HULC, now under military development by Lockheed Martin, and the current developers of EksoNR, which allows patients who are relearning to walk the ability to stand and take steps. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community.

Notícias